Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The United States led the world in developing the technology that beat the COVID-19 pandemic. Action from lawmakers may leave ...

Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...

In his resignation letter, Marks wrote that health secretary Robert F. Kennedy Jr. wanted "subservient confirmation of his ...

Robert F. Kennedy Jr. is set to significantly cut the size of HHS, reshaping the nation’s health agencies and closing ...

The sudden departure of Peter Marks, MD, from the FDA has prompted a chorus of criticism and despair from industry leaders and trade organizations.

The two most senior regulators in the agency’s vaccine office resigned in 2021 in part because of a Biden administration effort to expedite the licensing of Pfizer’s coronavirus shot and the ...

Robert F. Kennedy Jr.'s confirmation as Secretary of Health and Human Services has raised questions about future healthcare policy. However, Pfizer's foundation remains solid, based on strong cash ...

Not just IgG4 antibodies that become predominant in the many-jabbed, but also lesser studied IgG2, researchers find. NIH ...

What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...